Literature DB >> 762404

The cultural and biochemical characters of Streptococcus milleri strains isolated from human sources.

L C Ball, M T Parker.   

Abstract

A collection of 346 strains of Streptococcus milleri from a variety of human sources was examined culturally and biochemically, and for the presence of Lancefield group antigens. Most of the strains were non-haemolytic and ungroupable, but 25% were beta haemolytic and 19% were alpha haemolytic; 28% possessed a group antigen (A, 5%; C, 6%, F, 14%, G, 3%). These antigens were present in 69% of beta-haemolytic but in only 13% of alpha-haemolytic or non-haemolytic strains; beta haemolysis occurred in 82% of group-F strains, 43% of other groupable strains and 11% of ungroupable strains.The following reactions were given by > 80% of S. milleri strains: hydrolysis of arginine and aesculin, a positive Voges-Proskauer reaction, and acidification of trehalose, lactose, salicin and sucrose. A minority of strains showed enhancement of growth by CO(2), bile tolerance, NaCl tolerance, and ability to acidify other sugars, notably mannitol, raffinose and melibiose. Departures from the modal pattern of biochemical reactions showed a weak correlation with the type of haemolysis and the presence or absence of a group antigen but were not sufficiently systematic for clear-cut subdivisions to be recognized within the species.S. milleri therefore appeared to comprise a ;central' group of non-haemolytic strains that rarely formed a Lancefield-group antigen, in which the aesculin reaction was nearly always positive, lactose was usually acidified, and a considerable minority showed enhancement of growth by CO(2) and bile tolerance. Deviations from this pattern were of two main types. (1) ;Loss' of one or more of these reactions, which tended to be associated with beta-haemolysis and presence of a group antigen. In these respects, alpha-haemolytic strains tended to occupy an intermediate position. (2) ;Gain' of the ability to acidify additional sugars, notably raffinose and melibiose or mannitol; this occurred mainly among otherwise typical non-haemolytic strains that were rarely groupable.Only 12% of isolations from the bloodstream of patients suffering from systemic infections were beta haemolytic and only 18% possessed a group antigen, but a considerably greater proportion of those from visceral abscesses were beta haemolytic (28%). Among isolations from superficial lesions in some body sites there were considerably greater proportions of beta-haemolytic and groupable strains; thus, nearly one-half of those isolated from the abdomen other than the female genital tract were beta-haemolytic and over one-half were groupable. On the other hand, strains from the teeth and gums were nearly always non-haemolytic and ungroupable, and most vaginal isolations were of non-haemolytic strains with a wide sugar-fermentation pattern.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 762404      PMCID: PMC2130127          DOI: 10.1017/s002217240002547x

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  12 in total

1.  [Pathogenic strains of Streptococcus viridans; streptocci found in dental abscesses and infiltrates in the region of the oral cavity].

Authors:  O GUTHOF
Journal:  Zentralbl Bakteriol Orig       Date:  1956-09

2.  Reciprocal replacement of oleic acid and CO2 in the nutrition of the minute streptococci and Lactobacillus leichmannii.

Authors:  R H DEIBEL; C F NIVEN
Journal:  J Bacteriol       Date:  1955-08       Impact factor: 3.490

3.  Carbon dioxide requirement of group F and minute colony G hemolytic streptococci.

Authors:  P LIU
Journal:  J Bacteriol       Date:  1954-09       Impact factor: 3.490

4.  Streptococcus milleri (Guthof); an indigenous organism of the human oral cavity.

Authors:  B Mejàre; S Edwardsson
Journal:  Arch Oral Biol       Date:  1975-11       Impact factor: 2.633

5.  The application of computers to the classification of streptococci.

Authors:  G Colman
Journal:  J Gen Microbiol       Date:  1968-01

6.  An M-associated protein antigen (MAP) of group A streptococci.

Authors:  J P Widdowson; W R Maxted; A M Pinney
Journal:  J Hyg (Lond)       Date:  1971-12

7.  The cell walls of streptococci.

Authors:  G Colman; R E Williams
Journal:  J Gen Microbiol       Date:  1965-12

8.  Streptococcus milleri in the appendix.

Authors:  P M Poole; G Wilson
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

9.  Streptococci and aerococci associated with systemic infection in man.

Authors:  M T Parker; L C Ball
Journal:  J Med Microbiol       Date:  1976-08       Impact factor: 2.472

10.  Antibiotic susceptibilities of streptococci from the mouth and blood of patients treated with penicillin or lincomycin and clindamycin.

Authors:  I Phillips; C Warren; J M Harrison; P Sharples; L C Ball; M T Parker
Journal:  J Med Microbiol       Date:  1976-11       Impact factor: 2.472

View more
  34 in total

Review 1.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Use of rapid carbohydrate utilisation test for identifying "Streptococcus milleri group".

Authors:  J M Whitworth; P W Ross; I R Poxton
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

3.  Fatal infection in neonates of 26 weeks' gestation due to Streptococcus milleri: report of two cases.

Authors:  R A Cox; K Chen; A L Coykendall; P Wesbecher; V C Herson
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

4.  Human Fc(gamma) receptors for differentiation in throat cultures of group C "Streptococcus equisimilis" and group C "Streptococcus milleri".

Authors:  L Lebrun; M Guibert; P Wallet; M M de Maneville; J Pillot
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

5.  Presumptive identification of "Streptococcus milleri" in 5 h.

Authors:  K L Ruoff; M J Ferraro
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  Clinical significance of Streptococcus milleri.

Authors:  P Van der Auwera
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

7.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

8.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

9.  Evaluation of the rapid strep system for species identification of streptococci.

Authors:  P C Appelbaum; P S Chaurushiya; M R Jacobs; A Duffett
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

10.  Role of beta-hemolytic group C streptococci in pharyngitis: incidence and biochemical characteristics of Streptococcus equisimilis and Streptococcus anginosus in patients and healthy controls.

Authors:  K Fox; J Turner; A Fox
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.